216 related articles for article (PubMed ID: 26843404)
1. Von Willebrand factor for menorrhagia: a survey and literature review.
Ragni MV; Machin N; Malec LM; James AH; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brambilla DJ
Haemophilia; 2016 May; 22(3):397-402. PubMed ID: 26843404
[TBL] [Abstract][Full Text] [Related]
2. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Ragni MV; Rothenberger SD; Feldman R; Nance D; Leavitt AD; Malec L; Kulkarni R; Sidonio R; Kraut E; Lasky J; Pruthi R; Angelini D; Philipp C; Hwang N; Wheeler AP; Seaman C; Machin N; Xavier F; Meyer M; Bellissimo D; Humphreys G; Smith KJ; Merricks EP; Nichols TC; Ivanco D; Vehec D; Koerbel G; Althouse AD
Lancet Haematol; 2023 Aug; 10(8):e612-e623. PubMed ID: 37385272
[TBL] [Abstract][Full Text] [Related]
3. Monitoring Therapy during Treatment of von Willebrand Disease.
Favaloro EJ; Pasalic L; Curnow J
Semin Thromb Hemost; 2017 Apr; 43(3):338-354. PubMed ID: 27472426
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand disease in the pediatric and adolescent population.
Mikhail S; Kouides P
J Pediatr Adolesc Gynecol; 2010 Dec; 23(6 Suppl):S3-10. PubMed ID: 20934894
[TBL] [Abstract][Full Text] [Related]
5. Women and von Willebrand disease: controversies in diagnosis and management.
Kadir RA; Chi C
Semin Thromb Hemost; 2006 Sep; 32(6):605-15. PubMed ID: 16977570
[TBL] [Abstract][Full Text] [Related]
6. Menorrhagia and bleeding disorders in adolescent females.
Halimeh S
Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
[TBL] [Abstract][Full Text] [Related]
7. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, diagnosis, and management of von Willebrand disease in India.
Ghosh K; Shetty S
Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
[TBL] [Abstract][Full Text] [Related]
10. Towards novel treatment options in von Willebrand disease.
Lenting PJ; Kizlik-Manson C; Casari C
Haemophilia; 2022 May; 28 Suppl 4():5-10. PubMed ID: 35521728
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis in von Willebrand Disease: Coming of Age?
Saccullo G; Makris M
Semin Thromb Hemost; 2016 Jul; 42(5):498-506. PubMed ID: 27253087
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
Chen YC; Chao TY; Cheng SN; Hu SH; Liu JY
Haemophilia; 2008 Jul; 14(4):768-74. PubMed ID: 18498402
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand disease: an important differential for menorrhagia.
Brooks MV
Adv Nurse Pract; 2006 Mar; 14(3):67-8. PubMed ID: 16548132
[No Abstract] [Full Text] [Related]
14. Diagnosis and management of adult patients with von Willebrand disease in South Australia.
Rodgers SE; Lloyd JV; Mangos HM; Duncan EM; McRae SJ
Semin Thromb Hemost; 2011 Jul; 37(5):535-41. PubMed ID: 22102197
[TBL] [Abstract][Full Text] [Related]
15. [An inherited hemostatic disorder as the cause of menorrhagia].
Leebeek FW; Lotgering FK
Ned Tijdschr Geneeskd; 2002 Mar; 146(12):545-8. PubMed ID: 11938574
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of von Willebrand disease in Iran.
Cohan N; Karimi M
Semin Thromb Hemost; 2011 Jul; 37(5):602-6. PubMed ID: 22102206
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of von Willebrand disease: a developing country perspective.
Nair SC; Viswabandya A; Srivastava A
Semin Thromb Hemost; 2011 Jul; 37(5):587-94. PubMed ID: 22102204
[TBL] [Abstract][Full Text] [Related]
18. New treatment approaches to von Willebrand disease.
Lavin M; O'Donnell JS
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):683-689. PubMed ID: 27913547
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand Disease-Specific Aspects in Women.
Eladly F; Miesbach W
Hamostaseologie; 2022 Oct; 42(5):330-336. PubMed ID: 36323280
[TBL] [Abstract][Full Text] [Related]
20. High dose of tranexamic acid for treatment of severe menorrhagia in patients with von Willebrand disease.
Mohri H
J Thromb Thrombolysis; 2002 Dec; 14(3):255-7. PubMed ID: 12913407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
